» Authors » Frederikke Kragh Clemmensen

Frederikke Kragh Clemmensen

Explore the profile of Frederikke Kragh Clemmensen including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 3
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Clemmensen F, Gramkow M, Simonsen A, Ashton N, Huber H, Blennow K, et al.
Alzheimers Res Ther . 2025 Jan; 17(1):26. PMID: 39838483
Background: For clinical implementation of Alzheimer's disease (AD) blood-based biomarkers (BBMs), knowledge of short-term variability, is crucial to ensure safe and correct biomarker interpretation, i.e., to capture changes or treatment...
2.
Gramkow M, Clemmensen F, Sjaelland N, Waldemar G, Hasselbalch S, Frederiksen K
Alzheimers Dement (Amst) . 2024 Aug; 16(3):e12628. PMID: 39086497
Highlights: We demonstrated the diagnostic performance of qLRP in Alzheimer's disease.The diagnostic models were robust in sensitivity analyses.qLRP may assist in the bedside diagnostic evaluation of Alzheimer's disease.
3.
Clemmensen F, Areskeviciute A, Lund E, Roos P
BMJ Case Rep . 2024 Feb; 17(2). PMID: 38388201
Variably protease-sensitive prionopathy (VPSPr) is a recently characterised rare subtype of sporadic prion disease, mainly affecting individuals with valine homozygosity at codon 129 in the prion protein gene, with only...
4.
McWilliam O, Gramkow M, Blaabjerg M, Clemmensen F, Hasselbalch S, Frederiksen K
J Neurol . 2024 Jan; 271(4):1707-1716. PMID: 38195895
Background: Anti-IgLON5 disease is a rare but potentially reversible cause of cognitive impairment, sleep disturbances, dysautonomia, and movement disorders. It is an autoimmune encephalitis which, due to its insidious onset,...
5.
Gramkow M, Clemmensen F, Waldemar G, Hasselbalch S, Frederiksen K
J Neurol Sci . 2023 Dec; 456:122856. PMID: 38154247
Background: Quantitative light reflex pupillometry (qLRP) may be a promising digital biomarker in neurodegenerative diseases such as Alzheimer's disease (AD), as neuropathological changes have been found in the midbrain structures...